These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31057296)

  • 1. Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients.
    Kamimura K; Sakamaki A; Kamimura H; Setsu T; Yokoo T; Takamura M; Terai S
    World J Gastroenterol; 2019 Apr; 25(15):1817-1827. PubMed ID: 31057296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.
    ;
    J Hepatol; 2018 Aug; 69(2):406-460. PubMed ID: 29653741
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based clinical practice guidelines for liver cirrhosis 2015.
    Fukui H; Saito H; Ueno Y; Uto H; Obara K; Sakaida I; Shibuya A; Seike M; Nagoshi S; Segawa M; Tsubouchi H; Moriwaki H; Kato A; Hashimoto E; Michitaka K; Murawaki T; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Jul; 51(7):629-50. PubMed ID: 27246107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol.
    Polis S; Fernandez R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):39-51. PubMed ID: 26447006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term management of cirrhosis. Appropriate supportive care is both critical and difficult.
    Habib A; Bond WM; Heuman DM
    Postgrad Med; 2001 Mar; 109(3):101-13. PubMed ID: 11265349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging liver and hepatitis.
    Junaidi O; Di Bisceglie AM
    Clin Geriatr Med; 2007 Nov; 23(4):889-903, viii. PubMed ID: 17923344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatology after Hepatitis C.
    Fitz JG
    Dig Dis; 2016; 34(5):603-6. PubMed ID: 27332966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tale of the Frail: Understanding Frailty in Cirrhosis.
    Pradhan F; Narang N; Fallon M
    South Med J; 2021 Mar; 114(3):186-191. PubMed ID: 33655314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The elder patient with advanced liver disease].
    Hopf U
    Praxis (Bern 1994); 2005 May; 94(18):743-50. PubMed ID: 15938386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.
    Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio HM; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
    J Hepatol; 2018 Mar; 68(3):393-401. PubMed ID: 29107152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
    Wali M; Harrison RF; Gow PJ; Mutimer D
    Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort).
    Gentile I; Scotto R; Coppola C; Staiano L; Amoruso DC; De Simone T; Portunato F; De Pascalis S; Martini S; Macera M; Viceconte G; Tosone G; Buonomo AR; Borgia G; Coppola N
    Hepatol Int; 2019 Jan; 13(1):66-74. PubMed ID: 30523552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.
    Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y
    Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
    Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.